Granulocyte colony-stimulating factor (G-CSF) could enhance Fcgamma receptor expression in neutrophils of patients with B-cell lymphoma treated with rituximab.
Sashida
Goro
G
Takaku
Tomo-Iku
TI
Honda
Seiko
S
Ishii
Yuko
Y
Yamaguchi
Noritaka
N
Sumi
Masahiko
M
Shoji
Nahoko
N
Gotoh
Akihiko
A
Shimamoto
Takashi
T
Ito
Yoshikazu
Y
Ohyashiki
Kazuma
K
D000911:Antibodies, Monoclonal / Q000008:administration & dosage; D058846:Antibodies, Monoclonal, Murine-Derived; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D004357:Drug Synergism; D005434:Flow Cytometry; D016179:Granulocyte Colony-Stimulating Factor / Q000008:administration & dosage; D006801:Humans; D016130:Immunophenotyping; D016393:Lymphoma, B-Cell / Q000188:drug therapy*; D009504:Neutrophils / Q000187:drug effects*; D017452:Receptors, IgG / Q000096:biosynthesis*; D000069283:Rituximab
D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D017452:Receptors, IgG; D016179:Granulocyte Colony-Stimulating Factor; D000069283:Rituximab